Altimmune, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Altimmune, Inc..The latest application filed is for "coronavirus immunogenic compositions and uses thereof".

Company Profile

17.21.24

Altimmune, Inc. - Gaithersburg MD
Altimmune, Inc - Gaithersburg MD US
Altimmune Inc. - Gaitherburg MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof Grant 11,395,802 - David , et al. July 26, 2	2022-07-26
Coronavirus immunogenic compositions and uses thereof Grant 11,382,968 - Georges , et al. July 12, 2	2022-07-12
Coronavirus Immunogenic Compositions And Uses Thereof App 20220072121 - Georges; Bertrand Victor Gilbert ; et al.	2022-03-10
Rapid and prolonged immunologic-therapeutic Grant 11,141,477 - Tang October 12, 2	2021-10-12
Coronavirus Immunogenic Compositions And Uses Thereof App 20210260181 - Georges; Bertrand Victor Gilbert ; et al.	2021-08-26
Coronavirus Immunogenic Compositions And Uses Thereof App 20210260180 - Georges; Bertrand Victor Gilbert ; et al.	2021-08-26
Rapid And Prolonged Immunologic-therapeutic App 20210260183 - Tang; De-chu C	2021-08-26
T-cell Inducing Vaccine Composition Combination And Uses Thereof App 20210236623 - Georges; Bertrand ; et al.	2021-08-05
Rapid and prolonged immunologic therapeutic Grant 11,040,099 - Tang June 22, 2	2021-06-22
Rapid and prolonged immunogic therapeutic Grant 11,040,100 - Tang June 22, 2	2021-06-22
Rapid And Prolonged Immunogic Therapeutic App 20200338183 - Tang; De-Chu C	2020-10-29
Immunizations Of Avians By Administration Of Non-replicating Vectored Vaccines App 20200338188 - Tang; De-Chu C ; et al.	2020-10-29
Rapid And Prolonged Immunogic Therapeutic App 20200338184 - Tang; De-Chu C	2020-10-29
Broad And Long-lasting Influenza Vaccine App 20200316188 - Roberts; Scot ; et al.	2020-10-08
Immunization of avians by administration of non-replicating vectored vaccines Grant 10,744,195 - Tang , et al. A	2020-08-18
Rapid And Prolonged Immunogenic-therapeutic App 20190134178 - TANG; De-chu C.	2019-05-09
Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax App 20190046630 - Huang; Chun-Ming ; et al.	2019-02-14
Rapid and prolonged immunologic-therapeutic Grant 10,183,069 - Tang Ja	2019-01-22
Immunization Of Avians By Administration Of Non-replicating Vectored Vaccines App 20180133306 - Tang; De-Chu C. ; et al.	2018-05-17
Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax Grant 9,968,667 - Huang , et al. May 15, 2	2018-05-15
Biodegradable Polymeric Particles Encapsulating An Active Agent, Pharmaceutical Compositions And Uses Thereof App 20180078507 - David; Allan E. ; et al.	2018-03-22
Immunization of avians by administration of non-replicating vectored vaccines Grant 9,855,328 - Tang , et al. January 2, 2	2018-01-02
Rapid and prolonged immunologic-therapeutic Grant 9,605,275 - Tang March 28, 2	2017-03-28
Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax App 20160114020 - Huang; Chun-Ming ; et al.	2016-04-28
Rapid And Prolonged Immunologic-therapeutic App 20160022797 - TANG; De-Chu C.	2016-01-28
Rapid and prolonged immunologic-therapeutic Grant 9,175,310 - Tang November 3, 2	2015-11-03

Company Registrations

NCAGE Code	1JRV4	ALTIMMUNE, INC.
NCAGE Code	1ZG60	ALTIMMUNE, INC.
CAGE Code	1JRV4	ALTIMMUNE, INC.
CAGE Code	1ZG60	ALTIMMUNE, INC.
S.A.M. Registration	1ZG60 [82804936]	ALTIMMUNE, INC.
SEC	0001326190	Altimmune, Inc. of DELAWARE
SEC	0001636613	Altimmune, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.